Oral Microbiota as Novel Biomarkers for Colorectal Cancer Screening
Authors:
- Sama RezasoltaniSRSama Rezasoltani
- Hamid Asadzadeh AghdaeiHAHamid Asadzadeh Aghdaei
- Seyedesomaye JasemiSJSeyedesomaye Jasemi
- Maria GazouliMaria Gazouli
- Nikolas DovrolisNikolas Dovrolis
- Amir SadeghiASAmir Sadeghi
- Hartmut SchlüterHartmut Schlüter
- Mohammad Reza ZaliMZMohammad Reza Zali
- Leonardo Antonio SechiLeonardo Antonio Sechi
- Mohammad Mehdi FeizabadiMFMohammad Mehdi Feizabadi
Open Access
Abstract
Alterations of the gut microbiome in cases of colorectal cancer (CRC) hint at the involvement of host–microbe interactions in the onset and progression of CRC and also, possibly, provide novel ways to detect and prevent CRC early. The aim of the present study was to evaluate whether the oral and fecal microbiomes of an individual can be suitable for CRC screening. Oral and fecal samples (n = 80) were gathered in Taleghani hospital, affiliated with Shahid Beheshti University of Medical Sciences, Tehran–Iran, from CRC stage 0 and I patients and healthy controls (HCs), who were screened for the first time. Microbial metagenomics assays were performed for studying microbiota profiles in all oral and fecal samples gathered. An abundance of top bacterial genera from both types of specimens (fecal and saliva samples) revealed a distinction between CRC patients and HCs. In saliva samples, the α diversity index was different between the microbiome of HCs and CRC patients, while β diversity showed a densely clustered microbiome in the HCs but a more dispersed pattern in CRC cases. The α and β diversity of fecal microbiota between HCs and CRC patients showed no statistically significant differences. Bifidobacterium was identified as a potential bacterial biomarker in CRC saliva samples, while Fusobacterium, Dialister, Catonella, Tennerella, Eubacterium-brachy-group, and Fretibacterium were ideal to distinguish HCs from CRC patients. One of the reasons for the heterogeneity of CRC may be the gastrointestinal (GI) tract microbiota, which can also cause systematic resistance to CRC. Moreover, an evaluation of saliva microbiota might offer a suitable screening test for the early detection of this malignancy, providing more accurate results than its fecal counterpart.Keywords
Funding Information
- Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences (RIGLD 1065)
- UNISS FAR fondi ricercar (RIGLD 1065)
- Fondazione di Sardegna (RIGLD 1065)
This publication has 52 references indexed in Scilit:
- Changes in Abundance of Oral Microbiota Associated with Oral CancerPLOS ONE, 2014
- Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinomaBMC Microbiology, 2012
- Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samplesGenome Biology, 2012
- Clinical Importance of Streptococcus gallolyticus Infection Among Colorectal Cancer Patients: Systematic Review and Meta-analysisClinical Infectious Diseases, 2011
- Genomic analysis identifies association of Fusobacterium with colorectal carcinomaGenome Research, 2011
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinomaGenome Research, 2011
- Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancerGut, 2011
- Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8Molecular Cancer, 2010
- SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARBNucleic Acids Research, 2007
- Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI: Journal of the National Cancer Institute, 2004